BNT323
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BNT323, covering 2026-03-05 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer [Phase 1, Phase 2]